Xilio Therapeutics (XLO) Debt Ratio (2020 - 2023)

Xilio Therapeutics (XLO) has 4 years of Debt Ratio data on file, last reported at 0.01 in Q1 2023.

• For the quarter ending Q1 2023, Debt Ratio fell 65.98% year-over-year to 0.01; the trailing twelve-month figure through Mar 2023 stood at 0.01 (down 65.98% YoY), and the FY2022 full-year result was 0.02, down 48.49% from the prior year.
• Debt Ratio eased to 0.01 in Q1 2023, from 0.02 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.2 in Q4 2020 to a low of 0.01 in Q1 2023.
• A 4-year average of 0.06 and a median of 0.04 in 2022 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio slumped 78.37% in 2021 and plunged 48.49% in 2022, its largest moves.
• Tracing XLO's Debt Ratio over 4 years: stood at 0.2 in 2020, then tumbled by 78.37% to 0.04 in 2021, then sank by 48.49% to 0.02 in 2022, then tumbled by 38.96% to 0.01 in 2023.
• Business Quant data shows XLO's Debt Ratio at 0.01 in Q1 2023, 0.02 in Q4 2022, and 0.03 in Q3 2022.